Form 8-K · Current report
Salesforce 8-K, filed Sep 4, 2026
- Filed
- CIK
- 0001108524
- Accession no.
- 0001108524-26-000197
Summary
Salesforce's Compensation Committee approved an executive deferred compensation plan under which eligible executives and other employees may defer up to 75% of base salary and 90% of annual performance bonus, with no employer match but possible discretionary company contributions and distributions by lump sum or installments.
Key points
- Salesforce's Compensation Committee approved the Salesforce, Inc. Executive Deferred Compensation Plan on September 2, 2026.
- Participants may defer up to 75% of base salary and up to 90% of any annual performance bonus.
- There is no employer match under the plan, though Salesforce may make discretionary contributions from time to time.
- Salesforce may establish a rabbi trust to help pay benefits, with trust assets remaining subject to the claims of general creditors in the event of insolvency.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (e) On September 2, 2026, the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Salesforce, Inc. (the “Company”) approved the Salesforce, Inc. Executive Deferred Compensation Plan (the “Plan”), pursuant to which executive officers and other eligible employees may elect to defer a portion of their compensation. The Company's obligations under the Plan are general unsecured and unfunded obligations to pay deferred compensation in the future in accordance with the terms of the Plan. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.